Tuesday, May 1, 2018

T cell biomarker predicts which CLL patients will respond to CAR T cell therapy

Researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don’t respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients’ immune systems are before the therapy is administered.



from Top Health News – ScienceDaily http://bit.ly/2Kv3KWy
from Tumblr http://bit.ly/2Kud8tF

No comments:

Post a Comment